Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gene therapy in the treatment of autoimmune diseases.

Literature DB >> 10903332

Gene therapy in the treatment of autoimmune diseases.

G C Tsokos¹, G T Nepom.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2000 PMID： 10903332 PMCID： PMC314315 DOI： 10.1172/JCI10575

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

33 in total

1. Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness.

Authors: Y Kang; M Melo; E Deng; R Tisch; M El-Amine; D W Scott
Journal: Proc Natl Acad Sci U S A Date: 1999-07-20 Impact factor: 11.205

Review 2. Oral tolerance: new approaches, new problems.

Authors: L Mayer
Journal: Clin Immunol Date: 2000-01 Impact factor: 3.969

Review 3. Mechanism of action of CpG DNA.

Authors: A M Krieg; G Hartmann; A K Yi
Journal: Curr Top Microbiol Immunol Date: 2000 Impact factor: 4.291

4. Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity.

Authors: D L Boyle; K H Nguyen; S Zhuang; Y Shi; J E McCormack; S Chada; G S Firestein
Journal: Gene Ther Date: 1999-12 Impact factor: 5.250

5. IGF-I gene transfer in thermally injured rats.

Authors: M G Jeschke; R E Barrow; H K Hawkins; K Yang; R L Hayes; B J Lichtenbelt; J R Perez-Polo; D N Herndon
Journal: Gene Ther Date: 1999-06 Impact factor: 5.250

6. Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes.

Authors: E T Zambidis; A Kurup; D W Scott
Journal: Mol Med Date: 1997-03 Impact factor: 6.354

7. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13.

Authors: N Bessis; M C Boissier; P Ferrara; T Blankenstein; D Fradelizi; C Fournier
Journal: Eur J Immunol Date: 1996-10 Impact factor: 5.532

8. Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts.

Authors: H G Zhang; N Huang; D Liu; L Bilbao; X Zhang; P Yang; T Zhou; D T Curiel; J D Mountz
Journal: Arthritis Rheum Date: 2000-05

Review 9. Gene therapy for autoimmune disease.

Authors: C G Fathman; G L Costa; C M Seroogy
Journal: Clin Immunol Date: 2000-04 Impact factor: 3.969

10. Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor.

Authors: J L Croxford; K A Triantaphyllopoulos; R M Neve; M Feldmann; Y Chernajovsky; D Baker
Journal: J Immunol Date: 2000-03-01 Impact factor: 5.422

5 in total

Gene therapy in the treatment of autoimmune diseases.

1. Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness.

Review 2. Oral tolerance: new approaches, new problems.

Review 3. Mechanism of action of CpG DNA.

4. Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity.

5. IGF-I gene transfer in thermally injured rats.

6. Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes.

7. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13.

8. Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts.

Review 9. Gene therapy for autoimmune disease.

10. Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor.

Review 1. Theory of traditional Chinese medicine and therapeutic method of diseases.

2. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis.

3. The TRAIL to arthritis.

4. Differentiation of Alginate-Encapsulated Wharton Jelly-Derived Mesenchymal Stem Cells into Insulin Producing Cells.

5. TLR-8, TNF-α, and ESR-1α Gene Polymorphism Susceptibility in Onset of Arthritis.